ASX
Island Pharmaceuticals Limited
ILA:ASX•Healthcare
Sensitive ASX Announcement
ILA submits IND to US FDA for Phase 2a PEACH clinical trial
Published: 28/12/22, 09:08am (AEST)•2 pages